Beckinam Nowatzke, MSc, RAC, is a global life sciences executive with 25+ years leading quality, regulatory, and continuous improvement across pharma, biotech, and medical devices. Known for scaling quality systems, authoring FDA submissions, and building cultures of innovation, she is now seeking board and advisory opportunities with organizations driving medical innovation, patient access, and regulatory excellence.

Ross Bundy is a pioneering biotechnology leader driving innovation in biosensor technology and genome editing optimization. As the CEO of CRISPR QC and co-founder of Cardea Bio Inc., he has been instrumental in developing platforms that enable real-time biological insights through the "Internet of Biology." With expertise in business development, financial strategy, and operational management, Bundy has successfully scaled multiple companies and forged key industry partnerships. His visionary leadership and strategic execution continue to shape the future of biotechnology, advancing diagnostics, therapeutics, and bioinformatics with cutting-edge solutions.

Peter Payne is a highly accomplished executive with over 30 years of leadership experience in the pharmaceutical, biotechnology, and contract research organization (CRO) industries. Known for his integrity and results-driven approach, Peter has successfully led organizations through periods of significant growth and transformation. With deep expertise in drug development, clinical trials, and corporate strategy, he has built a strong reputation for driving innovation and strategic partnerships. His leadership spans notable roles, including Vice President at Optum, President of Gennaker Bio, and CEO at multiple biotech companies. Peter’s ability to communicate complex strategies and foster cross-functional collaboration has made him a respected figure in the life sciences industry.

I am excited to share my professional journey, reflecting over 27 years of experience in the pharmaceutical and biotech sectors. From co-founding Vidara Therapeutics to leading commercialization efforts at Horizon and AVM Biotechnology, my passion for innovation and growth has been at the core of my work. Here is my biography.